Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Kansas City, Kansas 66160


A study of Oxaliplatin and Docetaxel followed by Cetuximab for head and neck cancer patients to determine their effect on the control and reduction of tumor size

Study summary:

This is a non-randomized, open-label, phase II study to assess the effects of oxaliplatin and docetaxel followed by epidermal factor-antibody (EGFR-AB) cetuximab on patients with previously treated recurrent /metastatic squamous cell carcinoma of the head and neck. Head and neck tissue will also be tested to determine if the protein Epidermal Growth Factor Receptor is present in the cancer cells.


Inclusion Criteria: - Histologically or cytologically confirmed recurrent SCCHN - 18 years or older - Tumor site accessible by biopsy - Measurable disease - Receiving no other therapy - ECOG performance status 0-1 - Adequate bone marrow, renal function and hepatic function Exclusion Criteria: - Active infection or fever within 3 days of treatment - Active CNS metastases - Prior malignancy within 5 years - Hypersensitivity to study drugs - Chemotherapy within 30 days of treatment - Concurrent investigational therapy within 30 days - Radiotherapy of more than 25% of bone marrow - Peripheral neuropathy of grade 2 or greater - Pregnant or lactating patients - History of allogeneic transplant - Active or previously treated HIV or Hepatitis B or C - Patients with a tracheostomy



Primary Contact:

Principal Investigator
Chao Huang, MD
University of Kansas

Backup Contact:


Location Contact:

Kansas City, Kansas 66160
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.